Karyopharm Therapeutics (kpti 3 10/15/25)
13F holders, Q3 2024 (September 30)1holders
$0.76avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Karyopharm Therapeutics (kpti 3 10/15/25) in their 13F filings. The largest holder was Exome Asset Management LLC ($1.5M).
- Company
- Karyopharm Therapeutics (kpti 3 10/15/25)
- CUSIP
- 48576UAA4
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1.5M |
| Exits | 0 | $0 |
Ownership 1 holders
| Exome Asset Management LLC | 1.03% | New | 2,000,000 | $1.5M |
"% of holder's portfolio" is KARYOPHARM THERAPEUTICS (KPTI 3 10/15/25)'s weight in each manager's 13F, not the share of Karyopharm Therapeutics (kpti 3 10/15/25) the manager owns.